Boston Trust Walden Corp Becton Dickinson & CO Transaction History
Boston Trust Walden Corp
- $14 Billion
- Q4 2024
A detailed history of Boston Trust Walden Corp transactions in Becton Dickinson & CO stock. As of the latest transaction made, Boston Trust Walden Corp holds 351,794 shares of BDX stock, worth $80.1 Million. This represents 0.57% of its overall portfolio holdings.
Number of Shares
351,794
Previous 355,955
1.17%
Holding current value
$80.1 Million
Previous $85.8 Million
7.0%
% of portfolio
0.57%
Previous 0.61%
Shares
30 transactions
Others Institutions Holding BDX
# of Institutions
1,802Shares Held
260MCall Options Held
1.27MPut Options Held
1.09M-
Vanguard Group Inc Valley Forge, PA26.7MShares$6.09 Billion0.11% of portfolio
-
Black Rock Inc. New York, NY22.3MShares$5.07 Billion0.12% of portfolio
-
State Street Corp Boston, MA14.1MShares$3.21 Billion0.13% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD12.3MShares$2.81 Billion0.32% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD12.1MShares$2.76 Billion1.7% of portfolio
About BECTON DICKINSON & CO
- Ticker BDX
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 285,195,008
- Market Cap $64.9B
- Description
- Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...